Showing results (91-100 of 163) with videos related to

Sort By:
Pageof 17
Journal of Carcinogenesis|April 20, 2013
Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cellsHiroe Ono, Dai Chihara, Fumiko Chiwaki, et al.
Oncogene|November 22, 2018
Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor microenvironmentMichinobu Umakoshi, So Takahashi, Go Itoh, et al.
Cancer Science|September 2, 2014
Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasionNobuaki Fujikuni, Hideki Yamamoto, Kazuaki Tanabe, et al.
Oncology Letters|February 20, 2016
Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancerHiroshi Kubo, Yoshihiko Kitajima, Keita Kai, et al.
Cancer Science|June 17, 2005
Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancerKazuyoshi Yanagihara, Misato Takigahira, Hiromi Tanaka, et al.
Oncotarget|November 10, 2018
Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in ratsKiyoshi Terawaki, Yohei Kashiwase, Miaki Uzu, et al.
Journal of Neuroendocrinology|June 27, 2018
Modulation of synaptic inputs in magnocellular neurones in a rat model of cancer cachexiaToru Yokoyama, Kiyoshi Terawaki, Kouichiro Minami, et al.
Cancer Science|November 29, 2013
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosisNaoya Sakamoto, Yutaka Naito, Naohide Oue, et al.
Oncology Reports|May 9, 2014
Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancerHtoo Zarni Oo, Kazuhiro Sentani, Naoya Sakamoto, et al.
British Journal of Haematology|August 4, 2010
Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphomaKeichiro Mihara, Kazuyoshi Yanagihara, Misato Takigahira, et al.
Pageof 17